Hypothesis

5 Matching Annotations

Oct 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design

2
1. scibot 11 Oct 2023
  
  in Public
  
  RRID:AB_10641291
  
  DOI: 10.1016/j.isci.2023.107952
  
  Resource: (BioLegend Cat# 350304, RRID:AB_10641291)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10641291
  
  What is this?
  
  RRID:AB_10641291
2. scibot 01 Oct 2023
  
  in Public
  
  RRID:AB_10641291
  
  DOI: 10.1016/j.isci.2023.107952
  
  Resource: (BioLegend Cat# 350304, RRID:AB_10641291)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10641291
  
  What is this?
  
  RRID:AB_10641291
Visit annotations in context

Tags

RRID:AB_10641291

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10558812/
Aug 2022
www.sciencedirect.com www.sciencedirect.com

Off-The-Shelf Third-Party HSC-Engineered iNKT Cells for Ameliorating GvHD While Preserving GvL Effect in the Treatment of Blood Cancers

1
1. scibot 17 Aug 2022
  
  in Public
  
  RRID:AB_10641291
  
  DOI: 10.1016/j.isci.2022.104859
  
  Resource: (BioLegend Cat# 350304, RRID:AB_10641291)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10641291
  
  What is this?
  
  RRID:AB_10641291
Visit annotations in context

Tags

RRID:AB_10641291

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004222011312
Nov 2021
www.sciencedirect.com www.sciencedirect.com

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

1
1. scibot 17 Nov 2021
  
  in Public
  
  350304
  
  DOI: 10.1016/j.xcrm.2021.100449
  
  Resource: (BioLegend Cat# 350304, RRID:AB_10641291)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:AB_10641291
  
  What is this?
  
  RRID:AB_10641291 RRIDCUR:Missing
Visit annotations in context

Tags

RRIDCUR:Missing

RRID:AB_10641291

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379121003177
Jan 2020
www.sciencedirect.com www.sciencedirect.com

Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:AB_10641291
  
  DOI: 10.1016/j.stem.2019.08.004
  
  Resource: (BioLegend Cat# 350304, RRID:AB_10641291)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:AB_10641291
  
  What is this?
  
  RRID:AB_10641291 RRIDCUR:Validated
Visit annotations in context

Tags

RRID:AB_10641291

RRIDCUR:Validated

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S193459091930339X